Related Experiment Videos

Epidemiology, pathogenicity and emerging resistances in Staphylococcus pasteuri: from mammals and lampreys, to man

Vincenzo Savini1, Chiara Catavitello, Azaira Bianco

  • 1Department of Transfusion Medicine, 'Spirito Santo' Hospital, Pescara, Italy. vincsavi@yahoo.it

Recent Patents on Anti-Infective Drug Discovery
|June 13, 2009
PubMed

Insights

Staphylococcus pasteuri, an emerging nosocomial pathogen, shows concerning antibiotic resistance. This review highlights its growing threat and discusses relevant patents.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Staphylococcus pasteuri is a coagulase-negative, Gram-positive bacterium.
  • It is increasingly implicated in nosocomial infections and blood product contamination.
  • Its role in human disease remains debated, but emerging resistance is a concern.

Purpose of the Study:

  • To review the current understanding of Staphylococcus pasteuri.
  • To highlight its emerging role as a pathogen.
  • To discuss its documented antibiotic resistance patterns and related patents.

Main Methods:

  • Literature review of Staphylococcus pasteuri.
  • Analysis of reported cases and resistance data.
  • Review of relevant patents.

Main Results:

  • Staphylococcus pasteuri exhibits resistance to multiple antibiotic classes, including methicillin/oxacillin, macrolides, and tetracyclines.
  • It also shows resistance to quaternary ammonium compounds.
  • Several patents related to Staphylococcus pasteuri and its treatment exist.

Conclusions:

  • Staphylococcus pasteuri is an emerging opportunistic pathogen with significant antimicrobial resistance.
  • Its clinical significance warrants further investigation.
  • Understanding resistance mechanisms and patent landscapes is crucial for future interventions.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...